checkAd
    Startseite > Aktien > Adamis Pharmaceuticals > Nachrichten
    Adamis Pharmaceuticals Aktie
    0,0500
     
    EUR
    -20,63 %
    -0,0130 EUR
    Letzter Kurs 22.05.23 Lang & Schwarz
    0,0400
     
    EUR
    118.110 STK
    Geldkurs 22.05.23
    0,0600
     
    EUR
    118.110 STK
    Briefkurs 22.05.23
    ISIN: US00547W2089 · WKN: A1XA2F · USA

    Neueste Nachrichten

    DMK Pharmaceuticals Regains Full Rights to Commercialize ZIMHI
    21.12.23 · globenewswire · Adamis Pharmaceuticals
    DMK Pharmaceuticals Regains Full Rights from US WorldMeds for SYMJEPI and Provides Corporate Update
    28.11.23 · globenewswire · Adamis Pharmaceuticals
    DMK Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
    14.11.23 · globenewswire · Adamis Pharmaceuticals
    DMK Pharmaceuticals Announces Presentation of Preclinical Results Comparing Effects of DPI-125 on Opioid Withdrawal Behaviors Versus Standard of Care for Opioid Use Disorder at SfN Neuroscience 2023
    13.11.23 · globenewswire · Adamis Pharmaceuticals
    DMK Pharmaceuticals Announces Inducement Option Grant Under Nasdaq Listing Rule 5635(c)(4)
    30.10.23 · globenewswire · Adamis Pharmaceuticals
    DMK Pharmaceuticals Announces Inducement Option Grant Under Nasdaq Listing Rule 5635(c)(4)
    20.10.23 · globenewswire · Adamis Pharmaceuticals
    DMK Pharmaceuticals Restructures Executive Team to Support Next Phase of Growth
    19.10.23 · globenewswire · Adamis Pharmaceuticals
    Adamis Pharmaceuticals Changes Name to DMK Pharmaceuticals to Reflect New Strategic Focus
    07.09.23 · globenewswire · Adamis Pharmaceuticals
    Adamis Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update
    21.08.23 · globenewswire · Adamis Pharmaceuticals
    Adamis Pharmaceuticals Announces Closing of $8.0 Million Public Offering
    04.08.23 · globenewswire · Adamis Pharmaceuticals
    Adamis Pharmaceuticals Announces Pricing of $8.0 Million Public Offering
    02.08.23 · globenewswire · Adamis Pharmaceuticals
    Adamis Pharmaceuticals to Fund ZIMHI Clinical Study with University of Leiden Opioid Expert
    28.07.23 · globenewswire · Adamis Pharmaceuticals